Oncology in Clinical Practice

Strona główna
Polska
Warsaw
Oncology in Clinical Practice

Dane kontaktowe, mapa i wskazówki, formularz kontaktowy, godziny otwarcia, usługi, oceny, zdjęcia, filmy i ogłoszenia od Oncology in Clinical Practice, Zdrowie i medycyna, Ulica Roentgena 5, Warsaw.

09/10/2025

How effective is encorafenib + binimetinib (E+B) beyond clinical trials? This multicentre real-world study shows encouraging outcomes across first-, second-, and third-line settings in BRAF-mutant advanced melanoma patients, with ORRs up to 58.5% and median PFS of 10.3 months in first-line therapy.

Authors: Anna M. Czarnecka, Piotr Błoński, Bożena Cybulska-Stopa, Wiesław Bal, Robert Dziura, Magdalena Ciążyńska, Krzysztof Ostaszewski, Katarzyna Krawczak, Łukasz Galus, Katarzyna Kozak, Natasza Kempa-Kamińska, Grażyna Kamińska-Winciorek, Marta Pabianek, Paweł Rogala, Tomasz Kubiatowski, Marcin Ziętek, Jacek Mackiewicz, Piotr Rutkowski

📖 Read the full article: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/107991

06/10/2025

Extra-gastrointestinal stromal tumours (EGISTs) rarely originate in the prostate. This case report of a 61-year-old male describes diagnosis, treatment with radical prostatectomy and adjuvant imatinib, and includes a literature review. A valuable addition to the limited data on prostatic EGISTs.

Authors: Tayyip İlker Aydın, Gökhan Öztürk, Muhammet Bekir Hacıoğlu, Ebru Taştekin, Dicle Tamer Türk, Aykut Alkan, Aysun Fatma Akkuş, İsmail Bayrakçı, Gizem Bakır Kahveci, Didem Divriklioğlu, Dicle Yurdatap Koç, Ece Demirdelen

Full text available at:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/106439

30/09/2025

Cemiplimab, an anti–PD-1 antibody, offers significant survival benefits in NSCLC. This review summarizes the practical aspects of cemiplimab use in NSCLC patients, according to the current drug program in Poland. Mechanisms of action and resistance are also discussed, along with findings from recent clinical trials such as EMPOWER-Lung 1 and EMPOWER-Lung 3.

Authors: Dariusz M. Kowalski, Ewa Kalinka, Katarzyna Stencel, Kamila Wojas-Krawczyk, Paweł Krawczyk, Adam Płużański, Damian Tworek, Rafał Krenke, Jacek Fijuth, Tadeusz Orłowski, Renata Langfort, Piotr Jaśkiewicz, Wojciech Naumnik, Rodryg Ramlau, Maciej Krzakowski

📖 Read the full text: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/106900

17/09/2025

Leukocytoclastic vasculitis is a rare but serious dermatologic toxicity associated with panitumumab in metastatic colorectal cancer. This case report of a 51-year-old man with biopsy-confirmed lesions highlights the importance of early recognition and effective management of such adverse events.

Authors: Oğuzhan Yıldız, Murat Araz, Melek Karakurt Eryılmaz, Ali Fuat Gürbüz, Talat Aykut, Engin Hendem, Fahriye Kılınç, Mehmet Artaç
📖 Full case available at:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/104263

15/09/2025

An ingenious analysis aimed to assess the impact of the COVID-19 pandemic on early melanoma diagnosis and treatment by comparing the thickness of melanoma tumours resected in the years before and after the outbreak.

Authors: Monika Dudzisz-Śledź, Magdalena Ciążyńska, Paweł Teterycz, Marta Pabianek, Marcin Zdzienicki, Maria Krotewicz, Monika Kondracka, Piotr Rutkowski
📖 Full text available at: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/104136

11/09/2025

In a cohort of 151 patients treated with immune-checkpoint inhibitors, 38% experienced immune-related adverse events (irAEs), most commonly thyroid dysfunction and dermal toxicity. While organ toxicities did not significantly impact overall or progression-free survival, vigilant toxicity management remains essential to maintain patients’ safety and quality of life during immunotherapy.

📄 Full article available at:
🔗 https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/101838

Authors: Anna Rudzińska, Pola Juchaniuk, Jakub Oberda, Kacper Ponikowski, Anna Rodzajewska, Mariola Janiszewska, Katarzyna Machulska-Ciuraj, Katarzyna Szklener

08/09/2025

A rare case of BRAF-negative melanoma of unknown primary presenting as a cardiac tumour.
After challenging diagnostics, the tumour was ultimately identified as melanoma of unknown primary.
Read the full text for a comprehensive description of the diagnostic investigation, treatment course, and literature review:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/104774

Authors: Magdalena K. Zielińska, Monika Dudzisz-Śledź, Krzysztof Ostaszewski, Aneta Borkowska, Anna M. Czarnecka

01/09/2025

This clinical vignette presents a case of an 82-year-old woman with HBV-associated cirrhotic hepatocellular carcinoma who achieved a favorable response to second-line immunotherapy with nivolumab.
Read the full case:
https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/105847

Authors: Joanna Filipow, Monika Żeleźnicka, Filip Grydź, Tomasz Sarosiek

27/08/2025

Nanoparticle-based drug delivery is redefining breast cancer treatment by improving tumor specificity and reducing systemic toxicity.
This review focuses on albumin- and chitosan-based nanocarriers, discussing their targeting mechanisms, therapeutic advantages, and current limitations to clinical use.

Authors: Bartłomiej P. Lisik, Aleksandra Sado, Wiktoria Rogowska, Jan W. Sroczyński, Olaf Rogowski, Oliwier Rogowski

📖 Read the full article: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/106843

26/08/2025

We are proud to announce that we are one of the Scientific Patrons of The Summit on Cardio-Oncology Excellence 2025 – a premier international event dedicated to bridging oncology and cardiology for better patient outcomes.

👉 Oncology in Clinical Practice – the official journal of the Polish Society of Clinical Oncology
👉 Onkologia w Praktyce Klinicznej – the Polish edition
👉 Our publishing house – Via Medica

We are thrilled to support the advancement of the cardio-oncology field!
🌐 https://cardiooncology.pl/

21/08/2025

Oral mucositis remains a significant challenge in oncology, often necessitating opioid intervention due to severe pain.
This review provides an overview of current MASCC/ISOO recommendations and emerging therapies, including topical morphine and photobiomodulation, while highlighting the urgent need for more research into pain-specific management.

Authors: Grzegorz W. Borowski, Maria Zasadzińska, Piotr Bakuła, Kamila Jałocha
📖 Read the full article: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/105698

19/08/2025

As a technological approach, non-coding RNAs (ncRNAs) may pave the way toward more precise and personalized oncology, with potential applications in diagnostics, prognosis, and targeted therapies.
This short review highlights the transformative potential of ncRNAs as promising biomarkers.

Authors: Bhavika Baweja, Prerna Vats, Chainsee Saini, Rajeev Nema
📖 Read the full article: https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/104466

Adres

Ulica Roentgena 5
Warsaw
02-781

Strona Internetowa

https://journals.viamedica.pl/oncology_in_clinical_practice, https://www.researchgate.net/journal/Oncology-in-Clinical-P

Ostrzeżenia

Bądź na bieżąco i daj nam wysłać e-mail, gdy Oncology in Clinical Practice umieści wiadomości i promocje. Twój adres e-mail nie zostanie wykorzystany do żadnego innego celu i możesz zrezygnować z subskrypcji w dowolnym momencie.

Skontaktuj Się Z Praktyka

Wyślij wiadomość do Oncology in Clinical Practice:

Skróty

Chcesz aby twoja praktyka była na górze listy Klinika w Warsaw?

Udostępnij

Kategoria

Zdrowie i medycyna